Annual Advances and Innovations in Endoscopic Oncology and Multidisciplinary Gastrointestinal Cancer Care
Annual Advances and Innovations in Endoscopic Oncology and Multidisciplinary Gastrointestinal Cancer Care Overview
The evolution of endoscopic techniques and technology has created challenges in keeping clinicians up to date. In addition, current educational and training programs for gastroenterologists lack the necessary cancer-specific components. As cancer treatment approaches continue to transform, the endoscopy field requires a forum for dialogues on how to adapt and adjust practices in light of new treatment options. This course aims to bridge a critical educational void specifically focusing on endoscopic techniques and the latest advancements in technology for the comprehensive care of cancer patients. Furthermore, it offers a platform for collaborative discussions among diverse healthcare professionals regarding the ever-evolving landscape of endoscopy in a rapidly changing field where guidelines are constantly evolving.
Through leading-edge lectures, case discussion and interactive question and answer sessions, this intensive 2-day program will provide participants with an enhanced ability to interpret and apply these best treatment options into their individual practices. In addition, this year’s program highlights a nursing and advanced practice provider course and a fellowship transition to practice course.
Medical oncologist, surgical oncologist, radiation oncologists in addition to gastroenterologists, radiologists, interventional radiologists, palliative care providers, advanced practice providers, nurses, and all other allied health care professionals interested in the subject matter.
- Integrate gastroenterologists with the multidisciplinary oncology team to effectively improve patient outcomes.
- Examine the use of new endoscopic technologies and procedures.
- Outline procedure focused NCCN guideline updates.
- Discuss the importance of multidisciplinary care and its role in endoscopic decisions.
- Identify and engage all essential partners in improving care by supporting technological advancement, research, and education on new technologies.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
JOIN US FOR THE
2024 Annual Advances and Innovations in Endoscopic
Oncology and Multidisciplinary Gastrointestinal
|Conference Venue||Airport & Distance to Venue|
Omni Montelucia Resort & Spa
|Sky Harbor International Airport: about 8 miles away|
|Scottsdale Municipal Airport: about 9.6 miles away|
|Deer Valley Airport: about 18 miles away|
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 8.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 8.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.
As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any ineligible company. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest, and an "ineligible company" as any entity producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Any potential conflicts relative to the previous disclosure have been resolved.
Written disclosure of all such relevant financial relationships will be provided in the activity handout and/or syllabus. Any potential conflicts relative to the previous disclosure have been resolved.
City of Hope further encourages faculty/authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.
- 8.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this Annual Advances and Innovations in Endoscopic Oncology and Multidisciplinary Gastrointestinal Cancer Care for a maximum of 8.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 8.00 Attendance
EXHIBITING/SPONSORSHIP AT THE Annual Advances and Innovations in Endoscopic Oncology and Multidisciplinary Gastrointestinal Cancer Care
City of Hope is pleased to offer the opportunity to exhibit and/or sponsor the Annual Advances and Innovations in Endoscopic Oncology and Multidisciplinary Gastrointestinal Cancer Care, an ACCME accredited conference addressing the endoscopic oncology and multidisciplinary gastrointestinal cancer care.
Exhibit space & sponsorship is available to companies interested in participating in this conference.
EXHIBITOR BOOTH/SPONSOR REGISTRATIONS CANNOT BE PROCESSED ONLINE.
Please contact the Department of Continuing Medical Education in order to receive more information, at email@example.com.
Acknowledgment of Commercial Support: Any and all grant support will be acknowledged at the conference via signage and will be listed in the conference materials.
You must be logged in to your account to complete your registration.
Under "Registrant Type" dropdown (above), select your Registration Fee depending on your profession and click "Add to Cart". Follow the payment prompts.
You will receive an email confirmation once you are registered.
*Early Bird Registration
(Before December 31, 2023)
(After December 31, 2023)
|Physician (General Session)||$300||$450|
|Student/Resident/Fellow (General Session)||$200||$200|
|APP/Nurse (General Session)||$100||$200|
|APP/Nurse Combo (General Session + APP/Nurse Workshop)||$200||$300|
|APP/Nurse Workshop Only (Saturday, February 23, 2024, ONLY)||Click here to Register for the Mastering Comprehensive GI Cancer Care: APP & Nursing Workshop.|
|City of Hope Physician (General Session)||$200||$200|
|Virtual (General Session Only)||$150||$150|
|**Industry/Commercial Employee Attendee||$1,500||$1,500|
|Conference Dinner (Attendee)||$50||$50|
|Conference Dinner (Guest)||$75||$75|
Registration Fee: Registration fee includes all conference sessions, CME Credit (if applicable), meals (breakfast and lunch), and refreshment breaks.
Optional: Conference Dinner on Friday, February 23, 2024 is not included in the registration fee, and would require a purchased ticket to attend. Attendee and Guest pricing available.***
Cancellation Policy: Early Bird Registrations are nonrefundable. Refund requests must be submitted in writing and postmarked no later than Monday, January 8, 2024. A $50 processing fee will be applied for all refunds. Requests postmarked after Monday, January 8, 2024, will not be honored. All refunds will be processed 30 days after the meeting concludes. In the event of unforeseeable circumstances that lead to the cancellation by the conference organizers, all registration fees will be fully refunded.
For questions, contact the Department of Continuing Medical Education at firstname.lastname@example.org or 626-218-5622.
*Early Bird Registrations are nonrefundable.
**Industry/Commercial Employee Attendee is defined as any individual employed by a for-profit, including biotech, financial and pharmaceutical.
***Registered attendees are invited to attend the Conference Dinner on Friday, February 23, 2024 at 5:30 PM. Attendee and Guest pricing available.